AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Aug 03 2020
Opinion
The Right Way to Get a Vaccine at ‘Warp Speed’
Scientists need to show us the data. And that’s exactly what they’re working on.
Coronavirus vaccines are rapidly advancing through the development pipeline. The University of Oxford’s vaccine is in large trials in Britain, Brazil and South Africa. In the United States, researchers just began enrolling around 30,000 volunteers to test Moderna’s vaccine, and more trials are starting
New York Times (Opinion)
May 04 2021
Headline Roundup
Pfizer Raises $3.5 Billion from Coronavirus Vaccines in First Quarter of 2021
Pfizer raised $3.5 billion in revenues from its coronavirus vaccine in the first quarter of 2021, the company announced Tuesday morning. This exceeded analysts’ expectations and accounted for 24% of the company’s $14.6 billion in quarterly earnings. Pfizer also raised its forecast for total 2021 coronavirus vaccine sales by over 70% to $26 billion; Moderna has forecasted $18.4 billion in 2021
New York Times (News)
Wall Street Journal (News) 
New York Post (News) 
Nov 23 2020
Headline Roundup
AstraZeneca-Oxford COVID-19 Vaccine Up to 90% Effective, Cheaper Than Alternatives
Pharmaceutical company AstraZeneca announced Monday that its COVID-19 coronavirus vaccine, developed in collaboration with Oxford University, could be as much as 90% effective. The vaccine does not require storage at below-freezing temperatures, allowing for easier distribution. This and other factors contribute to a cost of $2.50 per dose, much cheaper than the Moderna and Pfizer vaccines,
The Daily Wire
Wall Street Journal (News)
BuzzFeed News
Nov 20 2020
Analysis
Pfizer and BioNTech have applied for emergency approval for their Covid-19 vaccine
Just last week, Pfizer and BioNTech revealed that their experimental Covid-19 vaccine, called BNT162b2, was at least 90 percent effective in an early analysis. On Wednesday, the pharmaceutical and biotech companies reported that their vaccine was even more effective after it cleared more clinical trial benchmarks for safety and efficacy. And on Friday, they said they are requesting an
Vox
Aug 31 2022
Headline Roundup
FDA Authorizes Updated COVID-19 Booster Shots for Expected Fall Omicron Wave
The FDA updated its emergency use authorizations for the Pfizer-BioNTech and Moderna COVID-19 vaccines to include updated booster shots designed to fight the highly contagious BA.4 and BA.5 Omicron subvariants.
The updated booster shots came ahead of an expected fall or winter wave of COVID-19 cases. The U.S. currently has a seven-day average of about 90,000 daily new cases, but last
Fox News (Online News)
STAT
The Verge
May 06 2022
Headline Roundup
FDA Restricts J&J’s COVID-19 Vaccine for Some People Over Blood Clot Risk
U.S. regulators have strictly limited who can receive the Johnson & Johnson COVID-19 vaccine due to the risk of rare but severe blood clots.
The Food and Drug Administration (FDA) said Thursday that adults should only get the J&J shot if “they would otherwise not receive a COVID-19 vaccine” or if they can't receive one of the mRNA vaccines from Moderna and Pfizer. The shot will
NPR (Online News)
Associated Press
The Epoch Times
Dec 09 2020
News
As Covid-19 Vaccines Roll Out, States to Determine Who Gets Shots First
The U.S. is about to launch one of the most daunting public-health efforts in generations: swiftly distributing a Covid-19 vaccine across all 50 states, each of which will determine who gets priority.
As soon as this weekend, the Food and Drug Administration is expected to grant emergency approval to a Covid-19 vaccine from Pfizer Inc. PFE -1.41% and BioNTech SE. BNTX -1.95% Within 24
Wall Street Journal (News)
Sep 23 2020
News
Johnson & Johnson enters late-stage trial testing its coronavirus vaccine
Johnson & Johnson said Wednesday it has begun its phase three trial testing its potential coronavirus vaccine.
J&J is the fourth drugmaker backed by the Trump administration’s Covid-19 vaccine program Operation Warp Speed to enter late-stage testing. The others are Moderna, Pfizer and AstraZeneca.
The trial will enroll up to 60,000 adult volunteers across 215 locations in
CNBC
Dec 21 2020
Perspectives Blog
Weekly United News Roundup: Early Dec. Polls Found Americans of All Political Stripes Strongly Supported A New Coronavirus Stimulus Bill
Plus, a bipartisan “908 Coalition” and increased openness toward the vaccine
Congressional leaders announced an agreement on a $900 billion coronavirus relief bill Sunday night.
Polls conducted in early December found the desire for a new stimulus bill was shared among Democrats and Republicans alike. Republican enthusiasm somewhat lagged that of Democrats, but Republicans still
James Coan
Jan 28 2021
Headline Roundup
S. Africa COVID-19 Variant Detected In US; Vaccine Manufacturers Test Effectiveness Against It
The COVID-19 variant B.1351, first identified in South Africa, has been confirmed for the first time in the United States as vaccine developers test their drug's effectiveness against the new variant. The Svariant has raised concerns over being more contagious than other strains of the virus, and for potentially evading the immunity provided by antibodies. According to a release from the South
Reuters
New York Post (News)
Washington Post